← Back to Patent Explorer
EP0509402A1 Expired / Lapsed EP ⏱️ 0.0 years remaining

Substituted 3-(Pyridinylamino)-indoles and benzo[b]thiophenes, a process for their preparation and their use as medicaments

Assignee: Aventis Pharmaceuticals Inc
•
Filing: 1992-04-09
•
Granted: —
•
Expires: 2012-04-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to compounds of the formula I where R₁ is hydrogen, loweralkyl, loweralkenyl, loweralkynyl, arylloweralkyl, aminoloweralkyl, loweralkylaminoloweralkyl, formyl, loweralkylcarbonyl, aminoloweralkylcarbonyl or loweralkoxycarbonyl; the group -X-Y= is R₂ and R₃ being independently hydrogen or loweralkyl; W is hydrogen, halogen, hydroxy, loweralkoxy, arylloweralkoxy or where R₄ is hydrogen, loweralkyl or arylloweralkyl; R₅ is loweralkyl or arylloweralkyl; or alternatively the group as a whole is , R₆ being hydrogen, loweralkyl, aryl or arylloweralkyl; and Z is hydrogen, halogen, loweralkyl, nitro or amino; which are useful for alleviating various memory dysfunctions such as Alzheimer's disease, as modulators of neurotransmitter functions such as serotonergic and adrenergic, and as such are useful as antidepressants, anxiolytics, atypical antipsychotics, antiemetics, and for the treatment of personality disorders such as obsessive compulsive disorders.

Inventors

  • 👤 Richard Charles Effland
  • 👤 Joseph Thomas Klein
  • 👤 Lawrence Leo Martin

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-04 17:05
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D401/12; A; A61; A61P; A61P1/00; A61P1/08; A61P25/00; A61P25/18; A61P25/20; A61P25/24; A61P25/26; A61P25/28; C07D409/00; C07D409/02; C07D409/12; C07D413/00; C07D413/02; C07D413/10; C07D417/00; C07D417/02; C07D417/12

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 937 words
A process for the preparation of a compound of the formula I where R₁   is hydrogen, loweralkyl, loweralkenyl, loweralkynyl, arylloweralkyl, aminoloweralkyl, loweralkylaminoloweralkyl, formyl, loweralkylcarbonyl, aminoloweralkylcarbonyl or loweralkoxycarbonyl; the group -X-Y= is R₂ and R₃ being independently hydrogen or loweralkyl; W   is hydrogen, halogen, hydroxy, loweralkoxy, arylloweralkoxy or where R₄ is hydrogen, loweralkyl or arylloweralkyl; R₅ is loweralkyl or arylloweralkyl; or alternatively the group as a whole is , R₆ being hydrogen, loweralkyl, aryl or arylloweralkyl; and Z   is hydrogen, halogen, loweralkyl, nitro or amino; or a pharmaceutically acceptable acid addition salt thereof, which comprises a) reacting a compound of the formula V where Z is not NH₂, with a compound of the formulae or wherein R₂, R₃ and W are as defined, to form a compound of the formula I, wherein -X-Y=, W, Z and R₃ are as defined, and R₁ is hydrogen, b) optionally reacting a compound of the formula I, wherein -X-Y = is and R₃, W and Z are as defined, with a compound of the formula where R₇ is loweralkyl, to afford a compound of the formula I, where R₁ is the group where R₇ is loweralkyl, -X-Y = is and R₃, W and Z are as defined, c) optionally reacting a compound of the formula I as obtained in step b) above, with a loweralkyl halide of the formula R₂ Hal where R₂ is loweralkyl and Hal is chlorine or bromine or with a diloweralkylsulfate of the formula (R₂O)₂SO₂ to afford a compound of the formula I, wherein the group -X-Y = is where R₂ is loweralkyl, R₃, W and Z are as defined and R₁ is where R₇ is loweralkyl, d) optionally hydrolyzing a compound of the formula I as obtained in step c) above, to afford a compound of the formula I, wherein the group -X-Y = is where R₂ is loweralkyl, R₃, W and Z are as defined and R₁ is hydrogen, e) optionally reacting a compound of the formula I, wherein the group -X-Y = W, and R₃ are as defined, Z is as defined, but is not amino, R₂, if existent, is loweralkyl and R₁ is hydrogen, with a compound of the formula R₈-Hal, where R₈ is loweralkyl, loweralkenyl, loweralkynyl or arylloweralkyl and Hal is chlorine or bromine, to afford a compound of the formula I, wherein the group -X-Y=, W and R₃ are as defined, Z is as defined but is not amino, R₂, if existent, is loweralkyl and R₁ has the meaning of R₈ above, f) optionally reacting a compound of the formula I wherein -X-Y =, W and R₃ are as defined, Z is as defined but is not amino, R₂, if existent, is loweralkyl and R₁ is hydrogen, with a compound of the formula where Alk is a loweralkylene group and Hal is chlorine or bromine, to afford a compound of the formula I, wherein -X-Y =, W and R₃ are as defined, Z is as defined but is not amino, R₂, if existent, is loweralkyl and R₁ is the group and treating the compound obtained with hydrazine or methylamine to afford a compound of the formula I, where X-Y=, W and R₃ are as defined, Z is as defined but is not amino, R₂, if existent, is loweralkyl and R₁ is aminoloweralkyl, g) optionally reacting a compound of the formula I wherein -X-Y=, W and R₃ are as defined, Z is as defined but is not amino, R₂, if existent, is loweralkyl and R₁ is hydrogen, with a compound of the formula Hal-Alk-Hal wherein Alk is loweralkylene and Hal is chlorine or bromine, and reacting the product obtained with a compound of the formula R'NH₂, where R' is hydrogen or loweralkyl to afford a compound of the formula I, wherein -X-Y=, W and R₃ are as defined, Z is as defined but is not amino, R₂, if existent, is loweralkyl and R₁ is aminoloweralkyl or loweralkylaminoloweralkyl, h) optionally reacting a compound of the formula I, wherein -X-Y=, W and R₃ are as defined, Z is as defined but is not amino, R₂, if existent, is loweralkyl and R₁ is hydrogen, with a compound of the formula where R₉ is loweralkyl and Hal is chlorine or bromine, to afford a compound of the formula I, wherein -X-Y=, W and R₃ are as defined, Z is as defined, but is not amino, R₂, if existent, is loweralkyl and R₁ is loweralkylcarbonyl, i) optionally reacting a compound of the formula I, wherein -X-Y=, W and R₃ are as defined, Z is as defined but is not amino, R₂, if existent, is loweralkyl, and R₁ is hydrogen, with a compound of the formula where R is t-butyl or benzyl, Alk is loweralkylene and Hal is chlorine or bromine or with a compound of the formula where R and Alk are as defined, in the presence of dicyclohexylcarbodiimide, to afford a compound of the formula I, wherein R₁ is the group and subjecting the compound obtained to hydrolysis or catalytically hydrogenolysis to afford a compound of the formula I, wherein -X-Y=, W and R₃ are as defined, Z is as defined but is not amino, R₂, if existent, is loweralkyl and R₁ is aminoloweralkylcarbonyl, and j) optionally reducing a compound of the formula I, wherein -X-Y=, W and R₃ are as defined, Z is as defined but is not amino, R₂, if existent, is loweralkyl and R₁ is loweralkylcarbonyl, with a suitable reducing reagent to afford a compound of the formula I, wherein -X-Y=, W and R₃ are as defined, Z is as defined but is not amino, R₂, if existent, is loweralkyl and R₁ is loweralkyl.
Claim 2
Dependent Claim 19 words
A process as defined in claim 1, wherein the group -X-Y= is wherein R₂ and R₃ are as defined.
Claim 3
Dependent Claim 24 words
A process as defined in claim 2, where R₁ is hydrogen, loweralkyl, loweralkylcarbonyl, W is hydrogen or halogen and Z is hydrogen or halogen.
Claim 4
Dependent Claim 19 words
A process as defined in claim 3, where W is hydrogen or fluoro and Z is hydrogen or fluoro.
Claim 5
Dependent Claim 28 words
The process as defined in claim 4, wherein a compound selected from 3-(4-pyridinylamino)-1H-indole, N-(1H-indol-3-yl)-N-(4-pyridinyl)propanamide, 3-(3-fluoro-4-pyridinylamino)-1H-indole, 6-fluoro-3-(4-pyridinylamino)benzo[b]thiophene or 6-fluoro-3-(propyl-4-pyridinylamino)benzo[b]thiophene or a pharmaceutically acceptable acid addition salt therof, is prepared.
Claim 6
Dependent Claim 20 words
Use of a compound as defined in claim 1 for the preparation of a medicament, having memory dysfunction alleviating activity.
Claim 7
Dependent Claim 18 words
Use of a compound as defined in claim 1 for the preparation of a medicament having antidepressant activity.
Claim 8
Dependent Claim 18 words
Use of a compound as defined in claim 1 for the preparation of a medicament having anxiolytic activity.
Claim 9
Dependent Claim 18 words
Use of a compound as defined in claim 1 for the preparation of a medicament having antipsychotic activity.
Claim 10
Dependent Claim 18 words
Use of a compound as defined in claim 1 for the preparation of a medicament having antiemetic activity.
Claim 11
Dependent Claim 22 words
Use of a compound as defined in claim 1 for the preparation of a medicament having obsessive compulsive disorder alleviating activity .

References Cited (Backward Citations)

EP0049779A1 Cited
EP0200322A1 Cited
EP0345808A1 Cited
EP0402644A1 Cited
EP0417653A1 Cited
EP0429984A2 Cited

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag